+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Bioresorbable Polymers Market by Product Type (Polycaprolactone, Polyglycolic Acid, Polylactic Acid), Application (Drug Delivery, Orthopedics) - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989643
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bioresorbable Polymers Market size was estimated at USD 905.90 million in 2023, USD 998.48 million in 2024, and is expected to grow at a CAGR of 10.47% to reach USD 1,819.30 million by 2030.

Bioresorbable polymers are biodegradable, biocompatible, and noncytotoxic materials that are safely absorbed by the body. The physical and degradation properties of bioresorbable polymers allow these polymers to be used for various applications such as orthopedic fixation, vascular stents, tissue engineering, and controlled drug delivery. The usage of bioresorbable polymers is significantly growing for various clinical applications, including bone implants, sutures, and drug delivery devices. Additionally, the worldwide increasing prevalence of orthopedic disorders, including arthritis, osteoarthritis, and rheumatoid arthritis, expanded the need for bioresorbable polymers for fracture fixation in orthopedic surgery or soft-tissue fixation. Furthermore, bioresorbable materials are used to create micro-scale medical devices and manufactured from various types of natural or synthetic polymers, including thermoplastic polyurethane and metals such as magnesium. However, the availability of less expensive and conventional bioresorbable polymers is hampering the growth of the bioresorbable polymer market. The technological advances in orthopedic implants and surgical devices are creating opportunities for the market.

Regional Insights

The U.S. has a developed pharmaceutical industry owing to the highest spending in the healthcare sector and the contribution of pharmaceutical manufacturers to the growth of the market across the North American region. Furthermore, the growing prevalence of arthritis in countries such as the U.S., the UK, China, and India expanded the need for bioresorbable polymers. Furthermore, pharmaceutical research and development (R&D) activities are significantly growing owing to government funding, a huge patient population, low costs, and the availability of an R&D workforce. Additionally, South Korea’s government has invested USD 693 million into the pharmaceutical industry to enhance R&D for new drugs. The African Development Fund invested USD 6 million in developing the pharmaceutical sector in Southern and Eastern Africa, subsequently expanding the market scope in the African region. In addtion, the pharmaceutical industry is expanding in the United Arab Emirates (UAE) and Saudi Arabia owing to ongoing improvements and government investments in the healthcare sector, assisting in the market growth in the Middle East & Africa region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bioresorbable Polymers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bioresorbable Polymers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bioresorbable Polymers Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, Acuro Organics Limited, Aduro Biopolymers LP, Advanced Polymer Materials Inc., Anhui Jumei Biological Technology Co., Ltd., Ashland Inc., Avantium N.V., BMG Incorporated, CD Bioparticles, Celares GmbH, ChitoLytic, Corbion NV, Evonik Industries AG, Foster Corporation, Futerro Group, Galatea Surgical, Inc., Gebrüder Martin GmbH & Co. KG, Goodfellow Cambridge Ltd., Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., MAST Biosurgery, MCG BioComposites, LLC, Merck KGaA, Mitsui & Co., Ltd., Musashino Chemical Laboratory, Ltd., Nanjing Jiayi Sunway Chemical Co., Ltd., Nanosoft Polymers, NatureWorks LLC, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., PBI Performance Products, Inc., Plastics New Zealand, Poly-Med Incorporated, PolyClean Technologies, Inc., PolyNovo Limited, Polysciences, Inc., Putnam Plastics, QINGDAO SOCO NEW MATERIAL CO., LTD., REVA Medical, LLC, Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Stepan Company, Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Univar Solutions Inc., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc.

Market Segmentation & Coverage

This research report categorizes the Bioresorbable Polymers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Polycaprolactone
    • Polyglycolic Acid
    • Polylactic Acid
    • Polysaccharides
    • Proteins
  • Application
    • Drug Delivery
      • Oral
      • Parenteral
    • Orthopedics
      • Hip
      • Knee
      • Spine
      • Trauma
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Bioresorbable Polymers Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bioresorbable Polymers Market?
  3. What are the technology trends and regulatory frameworks in the Bioresorbable Polymers Market?
  4. What is the market share of the leading vendors in the Bioresorbable Polymers Market?
  5. Which modes and strategic moves are suitable for entering the Bioresorbable Polymers Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bioresorbable Polymers Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surging availability of orthopedic devices with usage of bioresorbable polymers
5.1.1.2. Favorable reimbursement policies for several surgical procedures
5.1.1.3. Growing adoption of bioresorbable polymers for polymeric drug delivery and 3D printed medical implants
5.1.2. Restraints
5.1.2.1. Availability of cheap and conventional bioresorbable polymers
5.1.3. Opportunities
5.1.3.1. Supportive government initiatives in research and development of bio-based bioresorbable polymer
5.1.3.2. Rising technological advances in orthopedic implants and surgical devices
5.1.4. Challenges
5.1.4.1. Barriers associated with the bioresorbable packaging
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Bioresorbable Polymers Market, by Product Type
6.1. Introduction
6.2. Polycaprolactone
6.3. Polyglycolic Acid
6.4. Polylactic Acid
6.5. Polysaccharides
6.6. Proteins
7. Bioresorbable Polymers Market, by Application
7.1. Introduction
7.2. Drug Delivery
7.3.1. Oral
7.3.2. Parenteral
7.3. Orthopedics
7.4.1. Hip
7.4.2. Knee
7.4.3. Spine
7.4.4. Trauma
8. Americas Bioresorbable Polymers Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Bioresorbable Polymers Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Bioresorbable Polymers Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
11.3.1. Merger & Acquisition
11.3.1.1. Collagen matrix acquires polyganics
11.3.1.2. Technip energies acquires Biosuccinium technology from DSM for bio-sourced and fully biodegradable polymers production
11.3.2. Agreement, Collaboration, & Partnership
11.3.2.1. Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
11.3.3. New Product Launch & Enhancement
11.3.3.1. Amerigo scientific launches polycaprolactone for bioprinting
11.3.4. Investment & Funding
11.3.4.1. Evonik backs Allay's development of pain therapy implants
11.3.4.2. Biotech startup String Bio raises $20M in funding from Woodside Energy Group, others
11.3.5. Award, Recognition, & Expansion
11.3.5.1. Ashland expands bioresorbable development site in Ireland
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. 3D Biotek LLC
12.1.2. Acuro Organics Limited
12.1.3. Aduro Biopolymers LP
12.1.4. Advanced Polymer Materials Inc.
12.1.5. Anhui Jumei Biological Technology Co., Ltd.
12.1.6. Ashland Inc.
12.1.7. Avantium N.V.
12.1.8. BMG Incorporated
12.1.9. CD Bioparticles
12.1.10. Celares GmbH
12.1.11. ChitoLytic
12.1.12. Corbion NV
12.1.13. Evonik Industries AG
12.1.14. Foster Corporation
12.1.15. Futerro Group
12.1.16. Galatea Surgical, Inc.
12.1.17. Gebrüder Martin GmbH & Co. KG
12.1.18. Goodfellow Cambridge Ltd.
12.1.19. Huizhou Foryou Medical Devices Co., Ltd.
12.1.20. Koninklijke DSM N.V.
12.1.21. MAST Biosurgery
12.1.22. MCG BioComposites, LLC
12.1.23. Merck KGaA
12.1.24. Mitsui & Co., Ltd.
12.1.25. Musashino Chemical Laboratory, Ltd.
12.1.26. Nanjing Jiayi Sunway Chemical Co., Ltd.
12.1.27. Nanosoft Polymers
12.1.28. NatureWorks LLC
12.1.29. Nomisma Healthcare Pvt. Ltd.
12.1.30. Otto Chemie Pvt. Ltd.
12.1.31. PBI Performance Products, Inc.
12.1.32. Plastics New Zealand
12.1.33. Poly-Med Incorporated
12.1.34. PolyClean Technologies, Inc.
12.1.35. PolyNovo Limited
12.1.36. Polysciences, Inc.
12.1.37. Putnam Plastics
12.1.38. QINGDAO SOCO NEW MATERIAL CO., LTD.
12.1.39. REVA Medical, LLC
12.1.40. Rivika Bio Industries Pvt. Ltd.
12.1.41. SEQENS SAS
12.1.42. Solanyl Biopolymers Inc.
12.1.43. SpecialChem S.A.
12.1.44. Stahl Holdings B.V.
12.1.45. Stepan Company
12.1.46. Torise Biomaterials Co.,Ltd.
12.1.47. UBQ Materials Ltd.
12.1.48. Univar Solutions Inc.
12.1.49. Vibha Ecopac Pvt Ltd.
12.1.50. Zeus Industrial Products, Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. BIORESORBABLE POLYMERS MARKET RESEARCH PROCESS
FIGURE 2. BIORESORBABLE POLYMERS MARKET SIZE, 2023 VS 2030
FIGURE 3. BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIORESORBABLE POLYMERS MARKET DYNAMICS
FIGURE 7. BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BIORESORBABLE POLYMERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 6. BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BIORESORBABLE POLYMERS MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIORESORBABLE POLYMERS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 14. BIORESORBABLE POLYMERS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BIORESORBABLE POLYMERS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 18. BIORESORBABLE POLYMERS MARKET SIZE, BY HIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BIORESORBABLE POLYMERS MARKET SIZE, BY KNEE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BIORESORBABLE POLYMERS MARKET SIZE, BY SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. BIORESORBABLE POLYMERS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 35. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 38. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 39. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 42. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 57. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 60. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 61. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 64. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 69. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 72. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 93. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 96. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 110. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 113. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 114. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 117. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 121. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 125. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 130. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 133. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 142. NORWAY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. NORWAY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 145. NORWAY BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 146. POLAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. POLAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. POLAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 149. POLAND BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 150. QATAR BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. QATAR BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. QATAR BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 153. QATAR BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 169. SPAIN BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. TURKEY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 181. TURKEY BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 190. BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 191. BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. BIORESORBABLE POLYMERS MARKET LICENSE & PRICING

Companies Mentioned

  • 3D Biotek LLC
  • Acuro Organics Limited
  • Aduro Biopolymers LP
  • Advanced Polymer Materials Inc.
  • Anhui Jumei Biological Technology Co., Ltd.
  • Ashland Inc.
  • Avantium N.V.
  • BMG Incorporated
  • CD Bioparticles
  • Celares GmbH
  • ChitoLytic
  • Corbion NV
  • Evonik Industries AG
  • Foster Corporation
  • Futerro Group
  • Galatea Surgical, Inc.
  • Gebrüder Martin GmbH & Co. KG
  • Goodfellow Cambridge Ltd.
  • Huizhou Foryou Medical Devices Co., Ltd.
  • Koninklijke DSM N.V.
  • MAST Biosurgery
  • MCG BioComposites, LLC
  • Merck KGaA
  • Mitsui & Co., Ltd.
  • Musashino Chemical Laboratory, Ltd.
  • Nanjing Jiayi Sunway Chemical Co., Ltd.
  • Nanosoft Polymers
  • NatureWorks LLC
  • Nomisma Healthcare Pvt. Ltd.
  • Otto Chemie Pvt. Ltd.
  • PBI Performance Products, Inc.
  • Plastics New Zealand
  • Poly-Med Incorporated
  • PolyClean Technologies, Inc.
  • PolyNovo Limited
  • Polysciences, Inc.
  • Putnam Plastics
  • QINGDAO SOCO NEW MATERIAL CO., LTD.
  • REVA Medical, LLC
  • Rivika Bio Industries Pvt. Ltd.
  • SEQENS SAS
  • Solanyl Biopolymers Inc.
  • SpecialChem S.A.
  • Stahl Holdings B.V.
  • Stepan Company
  • Torise Biomaterials Co.,Ltd.
  • UBQ Materials Ltd.
  • Univar Solutions Inc.
  • Vibha Ecopac Pvt Ltd.
  • Zeus Industrial Products, Inc.

Methodology

Loading
LOADING...

Table Information